Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ofatumumab |
Trade Name | Arzerra |
Synonyms | HuMax-CD20 |
Drug Descriptions |
Arzerra (ofatumumab) is a monoclonal antibody that binds to CD20 and induces cytotoxic immune response against CD20 over-expressing cells (PMID: 26855591). Arzerra (ofatumumab) is FDA approved for chronic lymphocytic leukemia (FDA.gov). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | 679818-59-8 |
NCIT ID | C66952 |